Cargando…
New High-Affinity Thrombin Aptamers for Advancing Coagulation Therapy: Balancing Thrombin Inhibition for Clot Prevention and Effective Bleeding Management with Antidote
Thrombin is a key enzyme involved in blood clotting, and its dysregulation can lead to thrombotic diseases such as stroke, myocardial infarction, and deep vein thrombosis. Thrombin aptamers have the potential to be used as therapeutic agents to prevent or treat thrombotic diseases. Thrombin DNA apta...
Autores principales: | Ayass, Mohamad Ammar, Griko, Natalya, Pashkov, Victor, Tripathi, Trivendra, Zhang, Jin, Ramankutty Nair, Ramya, Okyay, Tutku, Zhu, Kevin, Abi-Mosleh, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526462/ https://www.ncbi.nlm.nih.gov/pubmed/37759453 http://dx.doi.org/10.3390/cells12182230 |
Ejemplares similares
-
Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease
por: Ayass, Mohamad Ammar, et al.
Publicado: (2022) -
Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system
por: Ayass, Mohamad Ammar, et al.
Publicado: (2022) -
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties
por: Hughes, Quintin W., et al.
Publicado: (2017) -
Crystal structures of thrombin in complex with chemically modified thrombin DNA aptamers reveal the origins of enhanced affinity
por: Dolot, Rafal, et al.
Publicado: (2018) -
The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro
por: Golderman, Valery, et al.
Publicado: (2016)